Alliance Pharma PLC | Cash Flow
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,009.00
10,157.00
15,182.00
22,219.00
28,910.00
18,356
Depreciation, Depletion & Amortization
688.00
795.00
438.00
429.00
933.00
1,546
Other Funds
-
503.00
-
-
-
4,697
Funds from Operations
11,354.00
10,273.00
14,937.00
20,993.00
22,504.00
26,036
Changes in Working Capital
2,783.00
596.00
7,985.00
6,479.00
1,505.00
7,027
Net Operating Cash Flow
8,571.00
10,869.00
6,952.00
14,514.00
24,009.00
19,009
Capital Expenditures
9,895.00
2,986.00
654.00
1,396.00
2,695.00
Purchase/Sale of Investments
-
499.00
-
1,018.00
154.00
Net Investing Cash Flow
9,915.00
3,485.00
134,504.00
8,440.00
16,016.00
Cash Dividends Paid - Total
2,040.00
2,398.00
2,643.00
5,152.00
5,729.00
Issuance/Reduction of Debt, Net
2,725.00
1,750.00
51,326.00
1,179.00
1,270.00
Net Financing Cash Flow
4,683.00
4,643.00
129,643.00
2,643.00
3,777.00
Net Change in Cash
6,099.00
2,770.00
2,178.00
4,023.00
3,963.00
Free Cash Flow
8,273.00
10,758.00
6,305.00
13,384.00
21,773.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
4,158.00
1,437
Net Assets from Acquisitions
-
-
-
-
17,475.00
Other Sources
-
-
-
-
4,000.00
Change in Capital Stock
82.00
8.00
80,960.00
1,330.00
682.00
Exchange Rate Effect
72.00
29.00
87.00
592.00
253.00
Other Uses
20.00
-
133,850.00
6,026.00
-
About Alliance Pharma
View Profile
